Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned a consensus rating of “Buy” from the ...

Scheduled for 13 weeks, the trial will assess the therapy’s safety, tolerability, and efficacy in weight loss.

Theratechnologies (THTX) said there will be a shortage of its drug Egrifta SV on the patient level in mid-January due to a ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

2-Year U.S. Treasury Note Continuous Contract $102.777-0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $106.078 0.000 0.00% 10-Year U.S. Treasury Note Continuous Contract $108.203-0.016 ...

It was a busy week in the biotech sector, with many regulatory and pipeline updates. Neumora Therapeutics NMRA plummeted on ...

He started all 17 games, playing 99 percent of the snaps. Outside linebacker Patrick Jones II (knee) was the only Viking who didn’t practice, and running back Aaron Jones Sr. (quad) was limited.

The wildfires ravaging Southern California are making no exceptions for fancy neighborhoods like the Pacific ...